Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Fiche publication
Date publication
juillet 2017
Journal
Drugs & aging
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MORIN Lucas
Tous les auteurs :
Grande G, Morin L, Vetrano DL, Fastbom J, Johnell K
Lien Pubmed
Résumé
Amyotrophic lateral sclerosis (ALS), with its certain prognosis and swift progression, raises concerns regarding the adequacy of pharmacological treatment, including the risk-benefit profiles of prescribed drugs.
Mots clés
Adult, Aged, Amyotrophic Lateral Sclerosis, drug therapy, Disease Progression, Drug Utilization, standards, Female, Humans, Male, Middle Aged, Odds Ratio, Prescription Drugs, administration & dosage, Prognosis, Retrospective Studies, Sweden, Terminal Care, standards
Référence
Drugs Aging. 2017 07;34(7):529-533